Demographic indicators and risk of infection with human herpesvirus type 8 in central Italy

被引:10
|
作者
Valdarchi, C.
Serraino, D.
Fei, P. Cordiali
Castilletti, C.
Trento, E.
Farchi, F.
Rezza, G.
机构
[1] IRCCS, Ctr Riferimento Oncol, UOC Epidemiol & Biostat, I-33081 Aviano, Italy
[2] Ist Super Sanita, Dept Infect Dis, Epidemiol Unit, I-00161 Rome, Italy
[3] Natl Inst Infect Dis L Spallanzani, IRCCS, Virol Lab, Rome, Italy
关键词
D O I
10.1007/s15010-007-5123-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: A cross-sectional study was conducted in Latium and Abruzzo Regions (Central Italy) to estimate the prevalence of infection with human herpesvirus type 8 (HHV-8) and the association between demographic indicators and risk of HHV-8 infection. Patients and Methods: Sera from 416 healthy individuals (>= 45 years of age), originally recruited in a multicentric case-control study on classic Kaposi's sarcoma (KS), were tested for antibodies against HHV-8. The association between demographic indicators (i.e., urban/rural residence, occupation) and HHV-8 seropositivity was assessed by means of multiple logistic regression (MLR) odds ratios (OR) and 95% confidence intervals (CI), adjusted for age and occupation. Results: Overall, 20.4% of the study participants had antibodies against HHV-8, 23.2% of the men and 17.0% of the women (p = 0.15). HHV-8 seropositivity rates significantly increased with age (p = 0.01), from 10.0% in those under 65 years of age to 24.9% in 75 years or older (MLROR = 2.4). By multivariate analysis, a significantly 2-fold higher risk of HHV-8 was found in individuals living in rural areas, as compared to those living in metropolitan/urban areas (MLR-OR = 2.0, 95% CI: 1.1-3.5), and in farmers, as compared to white collars (MLR-OR = 2.1, 95% CI: 1.1-4.1). Conclusions: The study findings suggest that demographic factors such as age, urban/rural residence, and occupation are associated with HHV-8 seropositivity among adult individuals living in central Italy.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 50 条
  • [21] Human herpesvirus 6 and human herpesvirus 8 infection in renal transplant recipients
    Deborska-Materkowska, D
    Wesolowska, A
    Paczek, L
    Durlik, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V183 - V183
  • [22] Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa
    Gessain, A
    Mauclère, P
    van Beveren, M
    Plancoulaine, S
    Ayouba, A
    Essame-Oyono, JL
    Martin, PMV
    de Thé, G
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (02) : 189 - 192
  • [23] Diagnosis and epidemiology of human herpesvirus 8 infection
    Martin, JN
    SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 133 - 142
  • [24] Multiple human herpesvirus-8 infection
    Beyari, MM
    Hodgson, TA
    Cook, RD
    Kondowe, W
    Molyneux, EM
    Scully, CM
    Teo, CG
    Porter, SR
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05): : 678 - 689
  • [25] Human herpesvirus 8 infection in hemodialysis patients
    Zavitsanou, A
    Sypsa, V
    Petrodaskalaki, M
    Psichogiou, M
    Katsoulidou, A
    Boletis, J
    Hadjiconstantinou, V
    Karalis, D
    Kalapothaki, V
    Hatzakis, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : 167 - 170
  • [26] Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: A meta-analysis
    Ge, Xiaoxiao
    Wang, Xiao
    Shen, Peng
    BIOMEDICAL REPORTS, 2013, 1 (03) : 433 - 439
  • [27] High seroprevalence of human herpesvirus type 8 infection in males with advanced lung carcinoma
    Cheng-Chuan Su
    Chun-Liang Lai
    Shih-Ming Tsao
    Ming-Nan Lin
    Tang-Yuan Chu
    Medical Microbiology and Immunology, 2015, 204 : 177 - 183
  • [28] Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China
    Dilnur, P
    Katano, H
    Wang, ZH
    Osakabe, Y
    Kudo, M
    Sata, T
    Ebihara, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (11) : 845 - 852
  • [29] Role of killer inhibitory receptors in human herpesvirus type 8 infection and KS development
    Sirianni, MC
    Libi, F
    Campagna, M
    Scaramuzzi, D
    Monini, P
    Ensoli, B
    IMMUNOLOGY 2004: IMMUNODEFICIENCY, INFECTIOUS DISEASES, IMMUNOMODULATION, AND VACCINES, 2004, : 257 - 259
  • [30] Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort
    Bernstein, KT
    Jacobson, LP
    Jenkins, FJ
    Vlahov, D
    Armenian, HK
    SEXUALLY TRANSMITTED DISEASES, 2003, 30 (03) : 199 - 204